Close

Analyst Ratings for Krystal Biotech (KRYS) [Sells]

KRYS Rating Summary

KRYS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KRYS
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $169.40 (+6.9%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details